Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Lung Cancer Group Cologne.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Lung Cancer Group Cologne
ClinicalTrials.gov Identifier:
NCT00568841
First received: December 5, 2007
Last updated: September 16, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
No publications provided by Lung Cancer Group Cologne

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):